Sepracor Estorra NDA Includes Data For Sleep Maintenance, Long-Term Use
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Sepracor’s recently submitted NDA for its sleep disorder agent Estorra seeks claims for improved sleep maintenance as well as long-term use.